This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy.
It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective.
Read more HERE.
Hey, future nephrology rockstars! 🎸 The ISN Young Nephrologists Committee (YNC) has... read more
Please join us in congratulating Professor Marie Trudel, the ISN 2025... read more
Kidney International® Outcomes From the International Society of Nephrology Hemolytic Uraemic Syndromes... read more
The ISN Educational Ambassadors Program (EAP) recently supported a training at... read more
The ISN supports education and professional development worldwide through its Continuing... read more
The High-impact Trials (HIT) sessions at WCN'25 promise exciting insights and... read more
This visual abstract was supported by Vera Therapeutics. Download Visual Abstract read more
Anita Layton, from the University of Waterloo, Canada, will present the... read more
The ISN congratulates its newest ISN-Named Fellows: Megan Borkum and Neeru Agarwal... read more
Are you exploring the potentially transformative role of artificial intelligence (AI)... read more
